True North makes partial exit from drug research firm with strong gains
Advertisement

True North makes partial exit from drug research firm with strong gains

By Ranjani Raghavan

  • 18 May 2017
Premium
True North makes partial exit from drug research firm with strong gains
Credit: Satyakam Banerjee/VCCircle

Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains from its second partial exit this year.It sold a 4.5% stake in Mumbai-listed Syngene International Ltd for Rs 427.50 crore ($65.8 million) through a block trade on Thursday, according to ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News